ESG Summary Report

Overview

The report describes the company's formalization of ESG governance, including expanded board-committee oversight of ESG strategy and practices. It highlights the Value for Patients Initiative, which addresses social, racial, economic, and bioethical challenges in cell and gene therapies. Environmentally, the company describes resource-efficiency measures while acknowledging that it is still collecting and analyzing data to understand its environmental footprint.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: Ends 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services